Wednesday, August 15, 2012

SUVEN LIFE SCIENCES LTD - FIRST QUARTER RESULTS - Q1 FY2013 - NET SALES UP 58%;NPT UP 137% YoY


SUVEN LIFE SCIENCES LTD

FIRST QUARTER RESULTS
Q1 FY2013

SUVEN LIFE SCIENCES is a  smaller Pharma Firm, which is progressing  gradually each quarter.

Here are its results for the first quarter ending  June 2012.

HIGH LIGHTS

Net Sales for Q1 FY 13 stands at Rs.70.53 Cr; up by 12.82% from the previous quarter of Q4 FY 12 (Rs.62.51 Cr); and up by  58.02 % from the corresponding Quarter of Q1 FY 12 (Rs.44.63 Cr).

Total Expenditure for Q1 FY 13 stands at Rs.59.02 Cr; up by 16.04% from the previous quarter of Q4 FY 12 (Rs.50.86 Cr); and up by  44.49% from the corresponding Quarter of Q1 FY 12 (Rs.   40.85 Cr).

Profit before Interest, Dep. & Taxes for Q1 FY 13 stands at Rs.11.50 Cr; down  by -1.25% from the previous quarter of Q4 FY 12 (Rs.11.65 Cr); and up by  204.06% from the corresponding Quarter of Q1 FY 12 (Rs.    3.38 Cr).

Net Profit for Q1 FY 13 stands at Rs.7.96 Cr; down  by -4.12% from the previous quarter of Q4 FY 12 (Rs.8.31 Cr); and up by  136.94% from the corresponding Quarter of Q1 FY 12 (Rs.  3.36 Cr).

Diluted EPS for Q1 FY 13 stands at Rs.0.68 ; Rs.0.71 in Q4 FY 12; Rs.0.29 in Q1 FY12 on a Face Value of Rs.1.

52 week high/low price : 18.90/11.10; Current Market price is also around Rs.18.30.

Paid-up Equity  is low at 11.67 Cr; Of this Public Holding is around 36.56%.

Suven claims to achieve a number of discoveries and patents periodically. Its Sales and profits are improving gradually from quarter to quarter. This will be an interesting company to watch.

RESULTS TABLE

Suven Life Sciences
30-Jun-12
QoQ % Dif
31-Mar-12
YoY%dif
30-Jun-11
31-Dec-11
30-Sep-11
Net Sales
7052.72
12.82
6251.37
58.02
4463.29
4863.7
4804.38
Total Expenditure
5902.25
16.04
5086.33
44.49
4084.92
4944.58
4705.95
Profit before Interest, Dep. & Taxes
1150.47
-1.25
1165.04
204.06
378.37
-80.88
98.43
Net Profit
796.34
-4.12
830.55
136.94
336.09
129.45
256.12
Diluted EPS
0.68
-4.23
0.71
134.48
0.29
0.11
0.22
Net Sales
7052.72
12.82
6251.37
58.02
4463.29
4863.7
4804.38
Cost of materials consumed
2144.63
-12.99
2464.72
15.67
1854.11
2125.68
1678.55
Employee benefits
651.73
29.43
503.54
38.23
471.47
583.66
594.21
Depreciation
183.23
33.46
137.29
32.08
138.73
138.27
140.02
Other expenses
2591.82
68.86
1534.92
58.89
1631.23
2976.45
2385.9
Total expenses
5902.25
16.04
5086.33
44.49
4084.92
4944.58
4705.95
Profit before tax
881.02
-2.35
902.25
274.79
235.07
-138.12
67.74
Tax Expenses
84.68
18.1
71.7
-183.82
-101.02
-267.57
-188.38
Net Profit
796.34
-4.12
830.55
136.94
336.09
129.45
256.12
Face Value(Rs )
1
0
1
0
1
1
1
Paid-up Equity
1167.32
0
1167.32
0
1167.32
1167.32
1167.32
Diluted EPS
0.68
-4.23
0.71
134.48
0.29
0.11
0.22
Public holding (%)
36.56
0
36.56
-0.44
36.72
36.56
36.86


 *  *  *  E  N  D  *  *

No comments:

Post a Comment